Enhancer ID: | E_01_1006 |
Species: | human |
Position : | chr5:171384232-171386232 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | acute myeloid leukaemia |
Pubmed ID: | 30942411 |
Enhancer experiment: | sequence |
Enhancer experiment description: | A total of 11 frequent mutations were identified, including nucleophosmin 1 (NPM1), Fms related tyrosine kinase 3 (FLT3), DNA methyltransferase 3? (DNMT3A) and Notch 2 (NOTCH2), with a mutation rate of ?10%. |
Target gene : | NPM1 |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | A total of 11 frequent mutations were identified, including nucleophosmin 1 (NPM1), Fms related tyrosine kinase 3 (FLT3), DNA methyltransferase 3? (DNMT3A) and Notch 2 (NOTCH2), with a mutation rate of ?10%. |
TF name : | -- |
TF experiment: | ?? |
TF experiment description: | A total of 11 frequent mutations were identified, including nucleophosmin 1 (NPM1), Fms related tyrosine kinase 3 (FLT3), DNA methyltransferase 3? (DNMT3A) and Notch 2 (NOTCH2), with a mutation rate of ?10%. |
Enhancer function : | A total of 11 frequent mutations were identified, including nucleophosmin 1 (NPM1), Fms related tyrosine kinase 3 (FLT3), DNA methyltransferase 3? (DNMT3A) and Notch 2 (NOTCH2), with a mutation rate of ?10%. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
A total of 11 frequent mutations were identified, including nucleophosmin 1 (NPM1), Fms related tyrosine kinase 3 (FLT3), DNA methyltransferase 3? (DNMT3A) and Notch 2 (NOTCH2), with a mutation rate of ?10%. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|